Bacillus alcalophilus peptidoglycan induces IFN-alpha-mediated inhibition of vaccinia virus replication

Ge Liu1, Qingzhu Zhai, Dustin Schaffner

  • 1Advanced Biosystems, Inc., George Mason University, 10900 University Blvd., MSN 1A8 Manassas, VA 20110, USA. ge.liu@analex.com

Insights

Bacterial peptidoglycan (PGN) enhances macrophage antiviral activity against poxviruses by boosting interferon-alpha (IFN-alpha) production. This suggests PGN as a potential therapeutic agent for viral infections.

Area of Science:

  • Immunology
  • Virology
  • Microbiology

Background:

  • Bacterial cell walls (CW) and peptidoglycan (PGN) are known immune activators.
  • Macrophages and NK cells play crucial roles in combating microbial infections.

Purpose of the Study:

  • To investigate the antiviral properties of bacterial CW and PGN against poxviruses.
  • To determine the specific bacterial components and immune pathways involved in antiviral activity.

Main Methods:

  • Murine macrophage cell line RAW 264.7 was treated with bacterial CW and PGN.
  • Vaccinia virus replication was measured.
  • Interferon (IFN) levels, nitric oxide (NO) production, and cytokine receptor expression were analyzed.
  • Neutralizing antibodies against cytokines and receptors were used.

Main Results:

  • Whole CW and PGN from four Gram-positive bacteria enhanced anti-poxviral activity in macrophages.
  • Peptidoglycan (PGN) from Bacillus alcalophilus was the most potent component, significantly increasing IFN-alpha levels.
  • Anti-IFN-alpha/beta antibody reversed PGN-induced inhibition of vaccinia virus replication and reduced NO production.

Conclusions:

  • Bacterial PGN enhances macrophage anti-poxviral activity primarily through inducing interferon-alpha (IFN-alpha).
  • Nitric oxide (NO) production is also involved, but to a lesser extent.
  • PGN demonstrates potential as an immunomodulatory agent against viral infections.